Concepedia

Author

Aruna Mahendravada

Baylor College of Medicine

Also Known As

A Mahendravada, Aruna Mahendravada

38

Publications

1.6K

Citations

8

H-Index

6

Concepts

All Affiliations

Baylor College of MedicineTexas Children's HospitalHouston MethodistMethodist HospitalBellicum Pharmaceuticals (United States)
AM

About

Aruna Mahendravada is an author at Baylor College of Medicine specializing in immunology, cell biology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

553

2

Cell Biology

1

1

553

3

Immunology

1

1

553

4

Autoimmunity

1

1

553

5

Hematology

1

1

553

Aruna Mahendravada

×

8

Publications

1.6K

Citations

8

H-Index

YearCitations

Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety

Valentina Hoyos, Barbara Savoldo, Concetta Quintarelli,

Leukemia

2010

553

T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model

Antonio Di Stasi, Biagio De Angelis, Cliona M. Rooney,

Blood

2009

522

Interleukin-7 Mediates Selective Expansion of Tumor-redirected Cytotoxic T Lymphocytes (CTLs) without Enhancement of Regulatory T-cell Inhibition

Serena Perna, Daria Pagliara, Aruna Mahendravada,

Clinical Cancer Research

2013

126

Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40

Aaron E. Foster, Aruna Mahendravada, Nicholas Shinners,

Molecular Therapy

2017

103

Safety and efficacy of targeting CD138 with a chimeric antigen receptor for the treatment of multiple myeloma

Chuang Sun, Aruna Mahendravada, Brandon Ballard,

Oncotarget

2019

91

Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies

Matthew R. Collinson-Pautz, Wei-Chun Chang, An Lu,

Leukemia

2019

78

Interleukin 15 Provides Relief to CTLs from Regulatory T Cell–Mediated Inhibition: Implications for Adoptive T Cell–Based Therapies for Lymphoma

Serena Perna, Biagio De Angelis, Daria Pagliara,

Clinical Cancer Research

2012

70

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Andreas Lundqvist, Vincent van Hoef, Xiaonan Zhang,

Journal for ImmunoTherapy of Cancer

2016

11

Page 1